Pharmaceutical peptide manufacturer

PolyPeptide Group - Peptide Synthesis and GMP Manufacturing

Menu Search Sections

Sections

• Home
• News
• Analysis
  • Features
  • Comment & Opinion
  • Projects
  • Data Insights
• Pharma
  • Clinical Trials
  • Drug Manufacturers
  • Therapy Area
    • Cardiovascular
    • Central Nervous System
    • Immunology
    • Infectious Disease
    • Oncology
    • Respiratory
  • Pricing and Market Access
• Themes
  • Artificial Intelligence
  • Corporate Governance
  • Cloud
  • Cybersecurity
  • Environmental Sustainability
  • Internet of Things
  • Robotics
  • Social Responsibility
  • Covid-19
• Insights
  • Deals
  • Jobs
  • Filings
  • Patents
  • Social Media
• Companies
  • Company A-Z
  • Company Categories
  • Products & Services
  • Company Releases
  • White Papers
  • Videos
  • Buyer's Guides
  • Partner Content
• Webinar & Events
  • Webinar & Events
  • All Webinars & Events
  • Events
  • Webinars
  • On-Demand Webinars
• Buy Reports
• Excellence Awards
• Innovation Rankings
• Magazine
• Newsletters

GlobalData

• About us
• Advertise With Us
• Contact Us
• Our Marketing Solutions
• GlobalData Reports
• Visit GlobalData

From Our Partners

• Biopharma Playbooks: Solutions at the Speed of Science
• Simplifying clinical data processes
• Control and confidence in clinical data management
• Optimizing Cell & Gene Therapy Processes
• Accelerating Biopharmaceutical Innovation
• Precision medicine and digital health innovation for disease diagnosis, care and treatment
• The next chapter of clinical trial services
• Putting quality first in the pharma supply chain
• Maximising molecule potential

News

Analysis

Sections

• Features
• Comment & Opinion
• Projects
• Data Insights

Latest

• Podcast: Which pharma and medtech companies came out on top in 2025 revenues?
• RNA-targeting small molecules: a new frontier of drug discovery
• Theranostics earmarked as “the future” of radiopharmaceuticals

Pharma

Sections

• Clinical Trials
• Drug Manufacturers
• Therapy Area
• Pricing and Market Access

Latest

• WHO wants improved universal vaccines to win global influenza battle
• Theranostics earmarked as “the future” of radiopharmaceuticals
• Significant opportunities exist in the global pain market for novel mechanisms and modalities

Themes

Sections

• Artificial Intelligence
• Cloud
• Corporate Governance
• Cybersecurity
• Environmental Sustainability
• Internet of Things
• Robotics
• Social Responsibility
• Covid-19
• Foreign Direct Investment

Latest

• SLE and LN market expected to reach $5.9bn across 7MM by 2034
• ZETA Facility Types
• Glass Cartridges

Insights

Sections

• Deals
• Jobs
• Filings
• Patents
• Social Media

Latest

• Immedica to buy Marinus Pharmaceuticals for $151m
• Private equity deals in pharmaceutical in Canada remained flat in Q3 2024
• Q3 2024 update: artificial intelligence related private equity activity in the pharmaceutical industry

Companies

Sections

• Company A-Z
• Company Categories
• Products & Services
• Company Releases
• White Papers
• Videos
• Buyer's Guides
• Partner Content

Latest

• OEB 6: The new standard in high-potent molecule manufacturing?
• RWD and RWE are rewriting how we design and run trials
• A New Strategic Blueprint: Designing Smarter Early Phase Trials in Oncology